XP13512 (Gabapentin Enacarbil) Extension Study in Patients With Restless Legs Syndrome.

Clinical trial NCT00333359 · COMPLETED

Trial details

NCT number: NCT00333359
Sponsor: XenoPort, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Restless Legs Syndrome

Start date: 2006-06-01
Primary completion: 2008-12-01
Enrollment: 581

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.